Description
CagriSema is a fixed-ratio combination of cagrilintide (amylin analogue) and semaglutide (GLP-1 receptor agonist) formulated as a single lyophilized research material. The combination enables investigation of simultaneous amylin and incretin pathway modulation, of interest in obesity and glycaemic control model research.
HALO Research Supplies provides this blend at ≥98% combined purity by HPLC, with batch COA. Available as 2.5+2.5 mg (5 mg total).
| Format | Lyophilized powder |
|---|---|
| Purity | ≥98% HPLC |
| Storage | −20°C desiccated |
Research Use Only. Not for human or veterinary use.
